Details of the Drug Combinations

General Information of This Drug (ID: DMZ9BMU)

Drug Name

Colistimethate DMZ9BMU

Synonyms

Colimicina; Colimyscine; Colimycin M; Colistimethale Sodium; Colistimethate sodium; Colistin Sulfomethate; Colistin methanesulfonate sodium salt; Colistin sodium methanesulfonate; Colistin sodium methanesulfonate from bacillus colistinus; Colistin sulfomethate sodium; Colistinemethanesulfonate sodique; Colistrimethate sodium; Colymycin M; Pentasodium colistinmethanesulfonate; Sodium colistimethate; Sodium colistin methanesulfonate; Sodium colistinemethanesulfonate; W 1929; Colistimethate sodium [USAN:INN]; Colistinmethanesulfonic acid, sodium salt; Coly-Mycin M; Coly-Mycin M Parenteral; Coly-mycin injectable

Indication

Disease Entry	ICD 11	Status	REF
Respiratory tract infection	CA45	Approved	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Antibiotics

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Meropenem + Colistimethate	DCUIHEZ	Meropenem	Gram-Negative Bacterial Infections	[2]
Rifampicin + Colistimethate	DC5O30T	Rifampicin	Infection Due to Resistant Bacteria	[3]
Minocycline + Colistimethate	DC0TCKI	Minocycline	Acinetobacter Infections	[4]
------------------------------------------------------------------------------------

References

1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 064216.
2	ClinicalTrials.gov (NCT01732250) Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
3	ClinicalTrials.gov (NCT01577862) Colistin and Rifampicin for MDR-Acinetobacter
4	ClinicalTrials.gov (NCT05586815) Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection